Publications by authors named "Roman Valiente"

Claim this Profile
B
Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study.
Belén Sádaba, Jose Ramón Azanza, Aintzane García-Bea, Luis Labeaga, Cristina Campo, Román Valiente

Eur J Drug Metab Pharmacokinet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.
Valvanera Vozmediano, John C Lukas, Esther Encinas, Stephan Schmidt, Ander Sologuren, Román Valiente

Eur J Pharm Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.
Amalia Leceta, Ander Sologuren, Román Valiente, Cristina Campo, Luis Labeaga

Drugs Context· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Rosa Antonijoan, Jimena Coimbra, Consuelo García-Gea, Montserrat Puntes, Ignasi Gich, Román Valiente

Curr Med Res Opin· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
Zoltán Novák, Anahí Yáñez, Ildikó Kiss, Piotr Kuna, Miguel Tortajada-Girbés, Román Valiente

Pediatr Allergy Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.
Pierre J L Valk, Ries Simons, Andrea M Jetten, Román Valiente, Luis Labeaga

Aerosp Med Hum Perform· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
Ignacio Jáuregui, Johannes G Ramaekers, Kazuhiko Yanai, Magí Farré, Esther Redondo, Román Valiente

Expert Opin Drug Saf· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
Magí Farré, Clara Pérez-Mañá, Esther Papaseit, Esther Menoyo, Marta Pérez, Román Valiente

Br J Clin Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.
Consuelo García-Gea, Joan Martínez, Maria Rosa Ballester, Ignasi Gich, Román Valiente

Hum Psychopharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.
Benoît Tyl, Meriam Kabbaj, Sara Azzam, Ander Sologuren, Román Valiente

J Clin Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
Joaquín Sastre, Joaquim Mullol, Antonio Valero, Román Valiente,

Curr Med Res Opin· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
Jean Bousquet, Ignacio Ansótegui, G Walter Canonica, Torsten Zuberbier, Carlos E Baena-Cagnani, Román Valiente

Curr Med Res Opin· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
Silke Conen, Eef L Theunissen, Anita C M Van Oers, Román Valiente, Johannes G Ramaekers

J Psychopharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
Consuelo García-Gea, Joan Martínez-Colomer, Rosa M Antonijoan, Román Valiente, Manuel-José Barbanoj

J Clin Psychopharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Mark Cooper, Ander Sologuren, Roman Valiente, Jeffery Smith

Arzneimittelforschung· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis